Rats were pretreated with either carbidopa (25 mg/kg 30 min previously) or phenelzine (50 mg/kg 18 h and 12 mg/kg 90 min previously) before being given 5-HTP (150 or 350 mg/kg) or paroxetine (12 mg/kg). In carbidopa-treated animals, 5-HTP (150 mg/kg) evoked many wet-dog shakes (WDS) without changing receptor numbers, but an increase in the dose of 5-HTP to 350 mg/kg paradoxically increased the number of cortical 5-HT2 receptors. The increase was reversed by pretreating the rats with haloperidol (5 mg/kg), but this did not occur with (250 mg/kg 16 h and 4 h before carbidopa). Apomorphine (2 mg/kg) in phenelzine-treated rats and apomorphine (10 mg/kg) in untreated rats increased 5-HT2 receptor numbers. The reason for the failure of 5-HTP to rapidly down-regulate 5-HT2 receptors is not known, but is thought to depend in some complex way on the proportion of 5-HTP that is decarboxylated to 5-HT outside serotonergic neurons, thus affecting the dopaminergic mechanism. In phenelzine-treated rats, paroxetine produced a 5-HT-dependent syndrome, which included WDS, and a significant reduction in cortical 5-HT2 receptors within 3 h. WDS were unaffected by administration of propranolol (20 mg/kg) or pindolol (5 mg/kg), confirming that WDS were independent of 5-HT1A receptors. The reduction of 5-HT2 receptors was not associated with migration of the receptors into the of the cortex, isolated by density-gradient centrifugation.
Introduction
Rat cortical 5-HT2 receptors are rapidly down-regulated by administering a 5-HT uptake inhibitor, such as fenfluramine, or 5-methoxydimethyltryptamine to animals pretreated with a monoamine oxidase (MAO) inhibitor [1, 2] . This downregulation is temporally associated with a reduced responsiveness of brain-stem and spinal cord 5-HT2 receptors, as evidenced from the reduced number of wet-dog Propranolol (20 mg/kg) was given 45 min before paroxetine (12 mg/kg) to rats pretreated with 2 injections of phenelzine (50 mg/kg 18h and 12 mg/kg 90 min previously), n=9. In the control group, rats were given saline instead of propranolol, n=9. Types of 5-HT-dependent behaviors were measured for 3h by the procedures described in Materials and Methods (with the exception of WDS maximum rated score of 48 from twelve 5-min observation periods). Table 1 Effects of propranolol on paroxetine-induced 5-HT-dependent bahaviors in to rats pretreated with phenelzine (50 mg/kg 18 mg/kg) had no effect when given to untreated rats (Fig. 5) .
Discussion
The present results extend earlier findings that in rats pretreated with an MAO inhibitor, 5-HT synthesized from exogenous 5-HTP does not affect 5-HT2 receptors in the same way as endogenous 5-HT released spontaneously from nerve terminals (in the presence of a 5-HT uptake inhibitor) or by a releasing agent [1, 2] After fenfluramine or a 5-HT uptake inhibitor, endogenous 5-HT rapidly produced down-regulation of the receptors, whereas after 5-HTP, the amount of downregulation was small and it occurred only slowly, i.e., after 6 h in phenelzinetreated rats [2] and after 24 h in carbidopa-treated animals. An increased dose of 5-HTP in carbidopa-treated rats had a paradoxical effect of increasing receptor number in the short term, although by 24 h there was a small but significant decrease in receptor number. On the other hand, although endogenous 5-HT was decreased by para-chlorophenylalanine (300 mg/kg 3 days previously), its administration did not affect the 5-HT2 receptor number. The reasons why rapid downregulation was not obtained by 5-HTP are not known. 5-HTP is decarboxylated to 5-HT by any cell containing aromatic amino acid decarboxylase and it can, for example, displace and release dopamine through formation of 5-HT within dopaminergic neurons [3, 4] . The finding of decreased WDS after a larger dose of 5-HTP was attributed to the inverted U-shaped dose-response curve of 5-HTP in carbidopa-treated rats, originally described by BEDARD and PYCOCK[11] with the 
